Balkhy cited the ongoing conflicts in Gaza, Sudan, and Yemen as areas where healthcare institutions and aid programmes were already under pressure before the funding shakeups.
In the Gaza Strip, where more than a year and a half of fighting has seen large swaths of the Palestinian territory reduced to rubble and few hospitals remain functioning, the public health situation is dire.
“The emergency medical team support, procurement of the medications and the rehabilitation of the health care facilities, all of that has been immediately impacted by the freeze of the US support,” said Balkhy.
In Sudan, the WHO is facing mounting issues amid a bloody civil war that has displaced millions, with several areas hit by at least three different disease outbreaks — malaria, dengue and cholera, according to Balkhy.
“We work significantly to identify emerging and re-emerging pathogens to keep the Sudanese safe, but also to keep the rest of the world safe. So it will impact our ability to continue to do surveillance, detection of diseases,” she added.
A US departure from the WHO will also undercut long established channels of communication with leading research facilities, universities and public health institutions that are based in the United States.
That in turn would likely prevent the easy sharing of information and research, which is pivotal to heading off global public health crises like an emerging pandemic, said Balkhy.
“These bacteria and viruses, number one, know no borders. Number two, they are ambivalent to what’s happening in the human political landscape.”
